+19,979.4%
TQQQ vs GSK
+188.5%
+19,790.9%
-81.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -15.9% | -0.1% | -15.8% | -15.8% |
| 7D | -28.6% | -5.3% | -23.2% | -24.3% |
| 30D | -43.3% | -3.7% | -39.6% | -41.3% |
| 3M | -41.4% | -7.3% | -34.2% | -37.7% |
| 6M | -45.9% | -4.2% | -41.7% | -46.3% |
| YTD | -21.4% | +0.9% | -22.3% | -28.9% |
| 1Y | -10.6% | +7.3% | -17.9% | -25.0% |
| 3Y | +90.4% | +52.7% | +37.7% | -12.9% |
| 5Y | -2.2% | +40.1% | -42.3% | -52.7% |
| 10Y | +1,592.2% | +98.7% | +1,493.5% | +411.1% |
| All | +19,979.4% | +188.5% | +19,790.9% | +2,944.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling